![John Hoekman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John D.
Hoekman is the founder.
He founded Ipi Legacy Liquidation Co. in 2008 and held the title of Chief Technology & Development Officer.
Dr. Hoekman has a doctorate degree from the University of Washington and an undergraduate degree from the University of Minnesota.
| Companies | Position | End |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
